NeuroSense Therapeutics Ltd. Ordinary Shares (NRSN) is a publicly traded Healthcare sector company. As of May 21, 2026, NRSN trades at $0.87 with a market cap of $27.81M and a P/E ratio of 0.00. NRSN moved +8.36% today. Year to date, NRSN is -7.99%; over the trailing twelve months it is -50.31%. Its 52-week range spans $0.63 to $2.60. Analyst consensus is strong buy with an average price target of $6.50. Rallies surfaces NRSN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
NeuroSense Therapeutics Ltd. Ordinary Shares (NRSN) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. NRSN moved +8.36% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $0.87 |
| Market Cap | $27.81M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $2.60 |
| 52-Week Low | $0.63 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
3 analysts cover NRSN: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $6.50.